Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · IEX Real-Time Price · USD
0.418
-0.032 (-7.13%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
5.81M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 0 | - | - |
| Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
| Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
| Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
| Mar 31, 2020 | 650.19K | 420.56K | 183.15% |
| Mar 31, 2019 | 229.63K | 80.00K | 53.47% |
| Mar 31, 2018 | 149.63K | -242.45K | -61.84% |
| Mar 31, 2017 | 392.07K | -494.50K | -55.78% |
| Mar 31, 2016 | 886.57K | 124.16K | 16.28% |
| Mar 31, 2015 | 762.42K | -861.35K | -53.05% |
| Mar 31, 2014 | 1.62M | 393.77K | 32.01% |
| Mar 31, 2013 | 1.23M | -129.62K | -9.53% |
| Mar 31, 2012 | 1.36M | - | - |
| Mar 31, 2011 | 0 | - | - |
| Mar 31, 2010 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Leafly Holdings | 40.05M |
| Biofrontera | 33.25M |
| ReShape Lifesciences | 8.34M |
| Evoke Pharma | 6.11M |
| Catheter Precision | 439.00K |
AEMD News
- 5 days ago - Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update - PRNewsWire
- 11 days ago - Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 - PRNewsWire
- 12 days ago - What's Next in Treatments for Cancer Patients with Solid Tumors? - Newsfile Corp
- 14 days ago - Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial - PRNewsWire
- 25 days ago - The Hunt for Virus Treatments Continues Post Covid-19 - Newsfile Corp
- 4 weeks ago - Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID - Newsfile Corp
- 4 weeks ago - Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies - PRNewsWire
- 6 weeks ago - Aethlon Medical Announces Pricing of $4.7 Million Public Offering - PRNewsWire